Marinus Pharmaceuticals (MRNS)
(Delayed Data from NSDQ)
$1.33 USD
+0.03 (2.31%)
Updated May 17, 2024 04:00 PM ET
After-Market: $1.34 +0.01 (0.75%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.59 | 0.00% |
Earnings Summary
For their last quarter, Marinus Pharmaceuticals (MRNS) reported earnings of -$0.68 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for MRNS's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.59 per share, reflecting a year-over-year increase of 3.28%.
Earnings History
Price & Consensus
Zacks News for MRNS
After Plunging -7.64% in 4 Weeks, Here's Why the Trend Might Reverse for Marinus Pharmaceuticals (MRNS)
MRNS: What are Zacks experts saying now?
Zacks Private Portfolio Services